1,402
Views
1
CrossRef citations to date
0
Altmetric
LETTER TO THE EDITOR

Second hematologic malignancies after ABVD: Two case reports and a retrospective study of 183 Hodgkin lymphoma patients

, , , , , , & show all
Pages 257-259 | Received 27 Jul 2009, Accepted 11 Aug 2009, Published online: 20 Oct 2009

References

  • Boivin JF, Hutchison GB, Zauber AG, Bernstein L, Davis FG, Michel RP, . Incidence of second cancers in patients treated for Hodgkin's disease. J Natl Cancer Inst. 1995; 87:732–41.
  • Kaldor JM, Day NE, Clarke EA, Van Leeuwen FE, Henry-Amar M, Fiorentino MV, . Leukemia following Hodgkin's disease. N Engl J Med. 1990; 322:7–13.
  • Swerdlow AJ, Barber JA, Hudson GV, Cunningham D, Gupta RK, Hancock BW, . Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: The relation to age at treatment. J Clin Oncol. 2000; 18:498–509.
  • Josting A, Wiedenmann S, Franklin J, May M, Sieber M, Wolf J, . The German Hodgkin's Lymphoma Study Group. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: A report from the German Hodgkin's Lymphoma Study Group. J Clin Oncol. 2003; 21:3440–6. Epub 2003 Mar 7.
  • van Leeuwen FE, Klokman WJ, Hagenbeek A, Noyon R, van den Belt-Dusebout AW, van Kerkhoff EH, . Second cancer risk following Hodgkin's disease: A 20-year follow-up study. J Clin Oncol. 1994; 12:312–25.
  • Tucker MA, Coleman CN, Cox RS, Varghese A, Rosenberg SA. Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med. 1988; 318:76–81.
  • Abrahamsen JF, Andersen A, Hannisdal E, Nome O, Abrahamsen AF, Kvaløy S, . Second malignancies after treatment of Hodgkin's disease: The influence of treatment, follow-up time, and age. J Clin Oncol. 1993; 11:255–61.
  • Munker R, Grützner S, Hiller E, Aydemir U, Enne W, Dietzfelbinger H, . Second malignancies after Hodgkin's disease: The Munich experience. Ann Hematol. 1999; 78:544–54.
  • Dietrich PY, Henry-Amar M, Cosset JM, Bodis S, Bosq J, Hayat M. Second primary cancers in patients continuously disease-free from Hodgkin's disease: A protective role for the spleen?. Blood. 1994; 84:1209–15.
  • Mauch PM, Kalish LA, Marcus KC, Coleman CN, Shulman LN, Krill E, . Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: Long-term analysis of risk factors and outcome. Blood. 1996; 87:3625–32.
  • Seow A, Koh WP, Shi LM, Lee HP, Shanmugaratnam K. Trends in cancer incidence in Singapore 1968–2002; Singapore Cancer Registry Report Number 6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.